Neonates have limited ability to regulate their own temperature, so keeping them at a normal body temperature avoids a high heat-producing stress on the body. When a baby becomes cold, the body ramps up metabolic activity to generate warmth, which sharply increases glucose use and oxygen demand. Because newborns often have limited glycogen stores and immature metabolic control, this cold stress can quickly lead to hypoglycemia. Cold stress also slows enzymatic reactions involved in the coagulation cascade and can impair platelet function, raising the risk of coagulopathy. By maintaining normothermia, you minimize energy expenditure, preserve glucose and substrate balance, and support stable acid-base and coagulation status, reducing the risk of serious morbidity. In practice, this is achieved through effective heat conservation and neutral-thermal environments, such as drying and warming the infant promptly, skin-to-skin contact when possible, and appropriate incubator or radiant warmer support.

Understanding the coagulation cascade and what each factor does helps explain why Hemophilia A is due to Factor VIII deficiency. Factor VIII serves as a crucial cofactor for Factor IXa in the intrinsic pathway, forming the tenase complex that converts Factor X to Xa. Without enough Factor VIII, thrombin generation drops and the clot formed is weaker, leading to spontaneous bleeding and prolonged bleeding after injury. This deficiency mainly shows up in laboratory testing as a prolonged activated partial thromboplastin time, while the prothrombin time remains normal because the extrinsic pathway is unaffected. Platelet function and platelet counts are typically normal in Hemophilia A, so bleeding patterns aren’t due to platelet problems. Hemophilia A is X-linked recessive, so it’s more common in males. A deficiency of Factor IX would cause a similar bleeding picture (Hemophilia B), whereas a deficiency of Factor VII would prolong the PT because it affects the extrinsic pathway. A practical clinical note: mild Hemophilia A can respond to desmopressin by releasing stored Factor VIII, while severe cases require Factor VIII replacement.

Maintaining a steady positive airway pressure to keep the lung units open is the essential idea here. Nasal CPAP delivers a continuous positive end-expiratory pressure through nasal prongs, which helps keep alveoli recruited, reduces work of breathing, and improves oxygenation in spontaneously breathing neonates. Because the pressure is continuous and easily titratable, it provides reliable, predictable support for mild-to-moderate respiratory distress without needing intubation, making it the standard initial noninvasive choice in many NICUs. Other options have their places in specific situations—high-flow can provide some PEEP but is less predictable in pressure delivery; nasal intermittent mandatory ventilation offers ventilator-driven breaths and is typically used when CPAP alone isn’t enough; bubble CPAP is a CPAP-based method that can be effective, but conventional nasal CPAP remains the most commonly used initial choice for mild-to-moderate distress.

Growth in neonates depends on supplying enough calories and protein and adjusting intake based on growth. Human milk is ideal, but for many preterm or growth-delayed babies its natural content may be insufficient, so fortifying the milk increases both calories and protein without losing the benefits of breast milk. If fortified human milk isn’t enough or available, using fortified formulas provides the necessary nutrients. Importantly, regular growth monitoring guides adjustments in nutrition so intake matches the baby’s evolving needs. Therefore, providing adequate calories and protein, fortifying human milk, considering fortified formulas, and monitoring growth is the best strategy. Avoiding fortification can leave the infant undernourished, using cow’s milk exclusively isn’t appropriate for neonates, and not monitoring growth misses opportunities to correct course.